Cite
HARVARD Citation
Mok, T. et al. (2016). A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma. Journal of thoracic oncology. 11 (10), p. . [Online].